Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)

NCT06668727 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: HepB mAb19

Sponsor

Aarhus University Hospital

Collaborators

[object Object]